Despite my youthful appearance they’ve finally given me a Covid jab | Séamas O’Reilly

Danmark Nyheder Nyheder

Despite my youthful appearance they’ve finally given me a Covid jab | Séamas O’Reilly
Danmark Seneste Nyt,Danmark Overskrifter
  • 📰 Lifestyle
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

I don’t mind injections, they make me feel brave and strong, but there’s one question I’m desperate to ask, says Séamas O’Reilly

I don’t mind injections, they make me feel brave and strong, but there’s one question I’m desperate to ask…

Vi har opsummeret denne nyhed, så du kan læse den hurtigt. Hvis du er interesseret i nyheden, kan du læse hele teksten her. Læs mere:

Lifestyle /  🏆 131. in UK

Danmark Seneste Nyt, Danmark Overskrifter

Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.

Covid-19 vaccine: Second jab date changes could 'jeopardise' rolloutCovid-19 vaccine: Second jab date changes could 'jeopardise' rolloutMore than a thousand have asked to change their appointment in recent days, say health officials.
Læs mere »

Pfizer Covid jab is approved for kids in UK in boost to vaccine blitzPfizer Covid jab is approved for kids in UK in boost to vaccine blitzBRITISH teens can now get the Pfizer Covid vaccine – as the jabs rollout speeds on to beat the variants. The UK’s medicine regulator MHRA has approved use of coronavirus shots for young…
Læs mere »

Covid vaccine to be offered to over 25s 'from next week' as second jabs sped upCovid vaccine to be offered to over 25s 'from next week' as second jabs sped upThe government wants to give out vaccines as quickly as possible with fears that the Indian variant is resilient to them especially after one dose. Over-40s are also set to get their second jab after eight weeks
Læs mere »

The pros and cons of giving Covid vaccines to UK childrenThe pros and cons of giving Covid vaccines to UK childrenAnalysis: the Pfizer/BioNTech jab has been approved for 12-15 year-olds but the risk-benefit equation is more complex than it is for for adults
Læs mere »



Render Time: 2025-04-18 20:36:00